Home
Home
About
Contact
Begin your search of the AGOSR Open Access Database
Search
Reset
All Fields
Contributors
DOI
OAI
Results: 6
View Article
Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson's Disease.
Robin J Borchert
,
Timothy Rittman
,
Luca Passamonti
,
Zheng Ye
,
Saber Sami
,
Simon P Jones
,
Cristina Nombela
,
Patricia Vázquez Rodríguez
,
Deniz Vatansever
,
Charlotte L Rae
,
Laura E Hughes
,
Trevor W Robbins
,
James B Rowe
Feb 09, 2016
Adrenergic Uptake Inhibitors
Aged
Atomoxetine Hydrochloride
Brain Mapping
Cross-Over Studies
Double-Blind Method
Female
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Neural Pathways
Parkinson Disease
Prefrontal Cortex
Published by:
View Article
Effective Use of Animal Models for Therapeutic Development in Psychiatric and Substance Use Disorders.
Anthony G Phillips
,
Mark A Geyer
,
Trevor W Robbins
Apr 11, 2018
Athina Markou and others argue forcefully for the adoption of a "translational-back translational strategy" for central nervous system drug discovery involving novel application of drugs with established safety profiles in...
Animal models
atomoxetine
Drug Discovery
Ketamine
Review
Varenicline
Adrenergic Uptake Inhibitors
Animals
Antidepressive Agents
Atomoxetine Hydrochloride
Attention Deficit Disorder with Hyperactivity
Depressive Disorder
Drug Discovery
Humans
Ketamine
Mental Disorders
Models
Animal
Nicotinic Agonists
Tobacco Use Disorder
Varenicline
Published by:
View Article
Prefrontal Cortex Activation and Stopping Performance Underlie the Beneficial Effects of Atomoxetine on Response Inhibition in Healthy Volunteers and Those With Cocaine Use Disorder.
Peter Zhukovsky
,
Sharon Morein-Zamir
,
Hisham Ziauddeen
,
Emilio Fernandez-Egea
,
Chun Meng
,
Ralf Regenthal
,
Barbara J Sahakian
,
Edward T Bullmore
,
Trevor W Robbins
,
Jeffrey W Dalley
,
Karen D Ersche
Sep 14, 2021
cocaine addiction
Connectivity
DCM
Impulsivity
Norepinephrine
stop-signal task
fMRI
Humans
Atomoxetine Hydrochloride
Adrenergic Uptake Inhibitors
Healthy Volunteers
Cross-Over Studies
INHIBITION
Psychological
Prefrontal Cortex
Cocaine
Published by:
View Article
Cross-species studies of cognition relevant to drug discovery
TW Robbins
Mar 02, 2018
Adrenergic Uptake Inhibitors
Animals
Atomoxetine Hydrochloride
Attention Deficit Disorder with Hyperactivity
Cognition
Depression
Drug Discovery
Humans
Obsessive-Compulsive Disorder
Reaction Time
Selective Serotonin Reuptake Inhibitors
Translational Research
Biomedical
Published by:
View Article
Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures.
Zheng Ye
,
Charlotte L Rae
,
Cristina Nombela
,
Timothy Ham
,
Timothy Rittman
,
Peter Simon Jones
,
Patricia Vázquez Rodríguez
,
Ian Coyle-Gilchrist
,
Ralf Regenthal
,
Ellemarije Altena
,
Charlotte R Housden
,
Helen Maxwell
,
Barbara J Sahakian
,
Roger A Barker
,
Trevor W Robbins
,
James B Rowe
Jan 14, 2016
Parkinson's Disease
Impulsivity
Machine Learning
Noradrenaline
Response inhibition
Serotonin
Stratification
Adrenergic Uptake Inhibitors
Aged
Atomoxetine Hydrochloride
Brain
Citalopram
Cross-Over Studies
Double-Blind Method
Female
Humans
INHIBITION
Psychological
Magnetic Resonance Imaging
Male
Neuropsychological Tests
Parkinson Disease
Prognosis
Psychomotor Performance
Psychotropic Drugs
Selective Serotonin Reuptake Inhibitors
Published by:
View Article
Locus coeruleus integrity and the effect of atomoxetine on response inhibition in Parkinson's disease.
Claire O'Callaghan
,
Frank H Hezemans
,
Rong Ye
,
Catarina Rua
,
P Simon Jones
,
Alexander G Murley
,
Negin Holland
,
Ralf Regenthal
,
Kamen A Tsvetanov
,
Noham Wolpe
,
Roger A Barker
,
Caroline H Williams-Gray
,
Trevor W Robbins
,
Luca Passamonti
,
James B Rowe
Mar 24, 2021
Parkinson’s disease
atomoxetine
Locus Coeruleus
neuromelanin imaging
Noradrenaline
Adrenergic Uptake Inhibitors
Aged
Atomoxetine Hydrochloride
Double-Blind Method
Female
Humans
INHIBITION
Psychological
Locus Coeruleus
Magnetic Resonance Imaging
Male
Middle Aged
Neuropsychological Tests
Parkinson Disease
Reaction Time
Published by: